Ouro Medicines is a biotechnology company developing immune reset therapeutics for chronic immune-mediated diseases, with a focus on B cell biology and T cell engagers.

Sudo Biosciences is a biopharmaceutical company developing TYK2 inhibitor candidates for the treatment of multiple sclerosis, neurodegenerative, and immune-mediated dermatologic diseases.